TAVR for severe low flow, low gradient aortic stenosis
Part of Heart & circulation clinical trials.
This study tests whether TAVR (a minimally invasive valve replacement) helps people with a specific type of severe aortic stenosis where the heart doesn't pump as strongly. It aims to see if the procedure improves symptoms and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a type of severe aortic stenosis called low flow, low gradient aortic stenosis, as diagnosed by current guidelines.
- You must be 18 years or older.
- You must be willing and able to give written informed consent.
- Your aortic stenosis must be confirmed as truly severe (not pseudo-severe) by a doctor.
- You cannot be already scheduled for medical treatment or open-heart surgery as your valve replacement plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This trial tests a procedure called TAVR to replace the aortic valve in people with severe aortic regurgitation (a leaky valve). It may help you if you have this condition and prefer a less invasive option than open-heart surgery.
This trial studies people with severe aortic valve disease who will receive a catheter-based valve replacement (TAVR). It aims to check how well this approach works for fixing a narrowed or leaky aortic valve, and to monitor outcomes afterward.
This study looks at how safe and effective an emergency heart valve replacement is for people with severe aortic stenosis who are in critical condition. It may help if you have severe symptoms like shock or unstable chest pain that need urgent treatment.
This study compares regular monitoring (“clinical surveillance”) versus replacing the aortic valve using a minimally invasive procedure called TAVR for people with moderate aortic stenosis. It aims to see which approach better reduces symptoms or heart damage over time.
This study checks whether an “investigational” transcatheter aortic valve is safe and works well for people with severe, calcified aortic stenosis (a stiff, narrowed heart valve). It may help improve valve function and symptoms, but you must meet specific heart, scan, and health-status requirements.
Hear when a new Low Flow, Low Gradient Aortic Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.